CRMD vs ED · P/E 3.9, rev $43.5M vs P/E 18, rev $15.26B
CorMedix Inc (CRMD) versus Consolidated Edison Inc (ED) — a side-by-side from cached financials, not a winner call.
CorMedix Inc (CRMD) is a biotechnology company listed on US.
Consolidated Edison Inc (ED) is a utilities - regulated electric company listed on US.
Latest reported CRMD revenue for 2024-12-31 was $43.5M. Net income was -$17.9M. Revenue was up 66363.1% from 2022-12-31 to 2024-12-31. CRMD currently screens at market cap $655.9M and trailing P/E 3.9.
Latest reported ED revenue for 2024-12-31 was $15.26B. Net income was $1.82B. Revenue was up 4.0% from 2023-12-31 to 2024-12-31. ED currently screens at market cap $36.02B and trailing P/E 18.3.
CRMD currently screens at market cap $655.9M and trailing P/E 3.9. ED currently screens at market cap $36.02B and trailing P/E 18.3.
Not investment advice. Open the CRMD and ED stock pages for the full models.
Not investment advice.